NASDAQ
No price data available for this timeframe.
Amphastar Pharmaceuticals, Inc. (AMPH) has a consensus Hold rating from 12 analysts with an average price target of $20.50, representing +5.6% upside from the current price of $19.41.
| Date | Analyst | Firm | Target | Price | Upside |
|---|---|---|---|---|---|
| Jun 3, 2026 | Unknown | Barclays | $20.00 | $18.45 | +8.40% |
| May 14, 2026 | Benjamin Burnett | Wells Fargo | $19.00 | $18.32 | +3.71% |
| May 11, 2026 | Unknown | Piper Sandler | $21.00 | $19.00 | +10.53% |
| Apr 20, 2026 | Dennis Ding | Jefferies | $22.00 | $22.92 |
Jun 3, 2026 | Maintained | Barclays | Equal Weight | Equal Weight |
May 14, 2026 | Downgrade | Wells Fargo | Overweight | Equal Weight |
May 11, 2026 | Maintained | Piper Sandler | Neutral | Neutral |
May 8, 2026 | Downgrade | Needham | Buy | Hold |
Apr 21, 2026 | Downgrade | Jefferies | Buy | Hold |
| -4.01% |
| Dec 8, 2025 | Unknown | Barclays | $30.00 | $26.01 | +15.34% |